tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ELEV Stock Latest News

Boeing upgraded, Lockheed downgraded: Wall Street’s top analyst calls
The FlyBoeing upgraded, Lockheed downgraded: Wall Street’s top analyst calls
5d ago
BA
CAG
Elevation Oncology: Strategic Shift to EO-1022 Amidst EO-3021 Discontinuation Justifies Hold Rating
PremiumRatings
Elevation Oncology: Strategic Shift to EO-1022 Amidst EO-3021 Discontinuation Justifies Hold Rating
7d ago
ELEV
Elevation Oncology downgraded to Equal Weight from Overweight at Stephens
PremiumThe Fly
Elevation Oncology downgraded to Equal Weight from Overweight at Stephens
7d ago
ELEV
Elevation Oncology price target lowered to $1 from $6 at H.C. Wainwright
PremiumThe Fly
Elevation Oncology price target lowered to $1 from $6 at H.C. Wainwright
10d ago
ELEV
Elevation Oncology downgraded to Neutral from Overweight at Piper Sandler
PremiumThe Fly
Elevation Oncology downgraded to Neutral from Overweight at Piper Sandler
10d ago
ELEV
Elevation Oncology’s Strategic Shift and Financial Stability Justify Hold Rating
PremiumRatingsElevation Oncology’s Strategic Shift and Financial Stability Justify Hold Rating
10d ago
ELEV
Elevation Oncology downgraded to Market Perform from Outperform at Citizens JMP
Premium
The Fly
Elevation Oncology downgraded to Market Perform from Outperform at Citizens JMP
10d ago
ELEV
Strategic Shift and Promising Developments Drive Buy Rating for Elevation Oncology
Premium
Ratings
Strategic Shift and Promising Developments Drive Buy Rating for Elevation Oncology
10d ago
ELEV
Elevation Oncology: Strategic Shift and Workforce Reduction Amid Clinical Setback
PremiumRatings
Elevation Oncology: Strategic Shift and Workforce Reduction Amid Clinical Setback
10d ago
ELEV
Elevation Oncology: Hold Rating Amidst Asset Discontinuation and Uncertain Prospects
PremiumRatings
Elevation Oncology: Hold Rating Amidst Asset Discontinuation and Uncertain Prospects
10d ago
ELEV
Elevation Oncology downgraded to Market Perform from Outperform at Leerink
PremiumThe Fly
Elevation Oncology downgraded to Market Perform from Outperform at Leerink
10d ago
ELEV
Elevation Oncology downgraded at Wedbush after EO-3021 discontinued
PremiumThe Fly
Elevation Oncology downgraded at Wedbush after EO-3021 discontinued
10d ago
ELEV
Elevation Oncology downgraded to Neutral from Outperform at Wedbush
PremiumThe FlyElevation Oncology downgraded to Neutral from Outperform at Wedbush
10d ago
ELEV
Elevation Oncology Restructures Amid EO-3021 Discontinuation
Premium
Company Announcements
Elevation Oncology Restructures Amid EO-3021 Discontinuation
11d ago
8K
ELEV
Elevation Oncology to discontinue development of EO-3021; Advancing EO-1022
Premium
The Fly
Elevation Oncology to discontinue development of EO-3021; Advancing EO-1022
11d ago
ELEV
Buy Recommendation for Elevation Oncology: Promising Pipeline and Strong Financial Management
PremiumRatings
Buy Recommendation for Elevation Oncology: Promising Pipeline and Strong Financial Management
21d ago
ELEV
Elevation Oncology’s Future in Jeopardy: Financing Challenges Threaten Product Development
PremiumCompany Announcements
Elevation Oncology’s Future in Jeopardy: Financing Challenges Threaten Product Development
23d ago
ELEV
Elevation Oncology Reports 2024 Financial Results and Progress
PremiumCompany Announcements
Elevation Oncology Reports 2024 Financial Results and Progress
23d ago
ELEV
Strategic Advancements and Financial Stability Drive Buy Rating for Elevation Oncology
PremiumRatings
Strategic Advancements and Financial Stability Drive Buy Rating for Elevation Oncology
23d ago
ELEV
Promising Outlook and Strong Financials Justify Buy Rating for Elevation Oncology
PremiumRatingsPromising Outlook and Strong Financials Justify Buy Rating for Elevation Oncology
24d ago
ELEV
Elevation Oncology reports Q4 EPS (18c), consensus (22c)
Premium
The Fly
Elevation Oncology reports Q4 EPS (18c), consensus (22c)
24d ago
ELEV
Elevation Oncology sees current cash and equivalents sufficient into 2026
Premium
The Fly
Elevation Oncology sees current cash and equivalents sufficient into 2026
24d ago
ELEV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >